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Abstract
To our knowledge, there have been only six S. warneri endocarditis cases reported in the English-language
literature (Medline: 1966 to April 2011). We report a case of recurrent S. warneri endocarditis in a patient with
prosthetic valve and silicon mammoplasty and we also review the relevant literature.
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Introduction
Coagulase-negative staphylococci (CoNS) have emerged
in recent years as important nosocomial pathogens, with
Staphylococcus epidermidis the most frequently recog-
n i z e do r g a n i s mi nt h i sg r o u p[ 1 ] .S. warneri and other
coagulase-negative staphylococci have been recognized
less frequently as significant human pathogens [2].
S. warnerii can cause catheter-related bacteremia,
native and prosthetic valve endocarditis (PVE), hemato-
genous vertebral osteomyelitis and ventriculoperitoneal
shunt-associated meningitis [3-10]. S. warnerii is a
CoNS that has rarely been reported in infective endocar-
ditis. To our knowledge, there have been only six S.
warneri endocarditis cases reported in the English-lan-
guage literature (Medline: 1966 to April 2011). We
report a case of recurrent S. warneri endocarditis in a
patient with prosthetic valve and silicon mammoplasty
and we also review the relevant literature.
Case Report
A 43-year-old immunocompetent woman presented with
a 20-day history of fever and night sweats. On the physical
examination, she had an axillary temperature of 38.5°C, a
heart rate of 90/min, a blood pressure of 90/70 mmHg
and a diastolic murmur (2/4) at the aortic area. Routine
chemistry panel and haemogram were normal. The C-
reactive protein (CRP) level was 28 g/dl (normal <5) and
had an erythrocyte sedimentation rate (ESR) of 30 mm/
hour. Three years ago, she had an aortic valve replacement
for congenital aortic stenosis. She had a silicon mammo-
plasty and dental extraction nine months and four months
ago respectively prior to this presentation. Three months
ago, she had been treated for S. warneri endocarditis with
ceftriaxone and gentamicin for four weeks. After one
month of being discharged from the cardiology depart-
ment, the patient developed fever and night sweats again.
On the second day of last hospitalization, painful nodules
(Oslers nodes) were noted in the pad of the right index
finger. We initiated empirical infective endocarditis treat-
ment with ampicillin-sulbactam and gentamicin. Transeo-
sphageal echocardiography revealed motile vegetation (15
mm × 4 mm in size) on the non-coronary cusp of the
prosthetic aortic valve with no significant aortic incompe-
tence. Three out of six blood culture bottles grew gram
positive cocci in clusters, later identified as methicillin-
sensitive (CoNS) (subsequently identified as S. warneri).
We used API ID 32 Staph system (a commercial test sys-
tem strip consists of 32 cupules, 26 of which contain dehy-
drated biochemical media for colorimetric tests to identify
staphylococci) (Bio-Merieux) for the definitive identifica-
tion of this bacterium.
On the seventh day of the treatment for the second
attack, she developed right hemiparesis and aphasia. Com-
puted tomography analysis showed a hypodense lesion in
the left fronto-temporal area compatible with infarction
and cerebral angiography revealed an aneurysm at the
bifurcation of the middle cerebral artery. The aneurysm
was successfully obliterated by a neurosurgical interven-
tion and hemorrhagic lesion eventually resolved. Ampicil-
lin-sulbactam and gentamicin was continued for a total of
eight weeks. She survived with minimal sequelae.
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PVE is usually health care-related and the infection
occurs in 1% to 3% of patients in the first postoperative
year of valve surgery. PVE is caused by CoNS in
approximately 15-40% of the cases. S. epidermidis is the
most common organism associated with prosthetic valve
endocarditis [11-13]. Especially, S. lugdunensis, S. capitis
have several virulence factors and have been described
to cause destructive native and prosthetic valve endocar-
ditis [14-16]. S. warneri rarely causes septicemia and
endocarditis. The case presented here is the seventh
endocarditis case due to S. warneri reported in the lit-
erature [4-7,9,10]. The relevant clinical data regarding
o u rc a s ea n dt h ep a t i e n t sw i t hS. warneri endocarditis
reported in the literature are given in Table 1. The
mean age of patients was 57 and all except three had
predisposing disease. Aortic valve was involved in six of
the patients and two patients had concomitant mitral
valve involvement. One patient had only mitral involve-
ment. Vegetation was observed in all of the patients on
ecocardiography. The mean duration of treatment was 6
weeks (4-8 weeks) and the beta-lactam and aminoglyco-
side combination was the preferred treatment choice.
Three of the isolates were methicillin resistant but van-
comycin sensitive. Ganesh D et al. were not reported
their isolate sensitivity and the patient treated with naf-
cillin for 6 weeks [10].
A case with infective endocarditis (a 71-y-old male
with a history of severe rheumatic aortic stricture, and
replacement of the aortic valve by a mechanic prosthetic
valve due to S. warneri has been reported by Abgrall S
al[7]. That patient was afebrile, and three blood cultures
were negative. The patient was empirically treated intra-
venously with vancomycin and gentamicin. Twenty days
later the patient went to the aortic valve replacement
for increased transvalvular pressure gradient. Upon sur-
gery, two vegetation tags and the valve revealed S. war-
neri on culture. In our case; S. warneri was isolated
from blood during both the first and the second infec-
tive endocarditis attack.
The increasing use of prosthetic devices and intravas-
cular catheters in contemporary healthcare has increased
the importance of CoNS as a cause of prosthetic valve
endocarditis. CoNS can colonize and produce a biofilm
on a biomaterial. This is an important virulence factor
in causing foreign body infections which are more indo-
lent by nature. There are previously reported two cases
of S. warneri endocarditis in which prosthesis (disc
prosthesis) were thought to be the resource of infection
[6,9]. Endocarditis took place nine months and one year
after implantation, respectively. Our patient had silicon
mammoplasty six months before the first attack. S. war-
neri endocarditis may directly develop due to procedures
w i t hf o r e i g nb o d i e sf o rt h eh e a r ts u c ha sp r o s t h e t i c
mechanic valve replacement, intracardiac defibrillator
and pacemaker implantation besides other procedures
with foreign bodies such as disk prosthesis. We thougt
that S. warneri endocarditis may be associated with a
catheter or other foreign materials such as silicon pros-
thesis/mechanic valve in the nosocomial setting.
As a conclusion; Sw a r n e r iinfective endocarditis is an
uncommon cause of infective endocarditis. This case
report is important because of the recurrence of S. war-
neri endocarditis. The reason for recurrence of S. warneri
endocarditis may be attributed to the biofilm occurrence
on the foreign material and shortness of the treatment
duration. The effective treatment should be maintained
for at least 6-8 weeks for endocarditis due to S. warneri.
Table 1 Clinical features and prognosis of patients with Staphylococcus warneri endocarditis reported in the literature
Reference Age/
Gender
Predisposing condition Valve involved Presence of vegetation
on echocardiography
Antibiotics and duration of therapy
4(1984) 32/M none Aortic valve Yes Penicilin+ Gentamicin
(4 weeks)
6(1989) 66/M disc prosthesis** Mitral, Aortic
Valve
yes NA*
3(1992) 64/M none Mitral, Aortic
Pulmonary Valve
No Vancomicin+
Gentamicin
7(2001) 71/M Prosthetic aortic valve Prosthetic aortic
valve
yes Vancomicin+ pefloxacine
(6 weeks)
9(2006) 48/M disc prosthesis** Aortic valve yes Vancomicin+Fucidic acid
(three day) Then
Rifampicin+Fucidic acid
10(2011) 78/W none Mitral valve yes Nafcicillin (6 weeks)
PRESENT
CASE(2008)
43/W Prosthetic aortic valve,
silicon mamoplasty**
Prosthetic aortic
valve
yes Ampicillin/sulbactam+ Gentamicin 2
weeks, Then 4 weeks amp/sulb.
Ampicilin/sulbactam
ampicillin/sulbactam
(8 weeks)
Not done
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